New Cancer Immunotherapy Agents in Development: A report from an associated program of the 31st Annual Meeting of the Society for Immunotherapy of Cancer, 2016 Journal Article
| Authors: | Adusumilli, P. S.; Cha, E.; Cornfeld, M.; Davis, T.; Diab, A.; Dubensky, T. W. Jr; Evans, E.; Grogan, J. L.; Irving, B. A.; Leidner, R. S.; Olwill, S. A.; Soon-Shiong, P.; Triebel, F.; Tuck, D.; Bot, A.; Dansey, R. D.; Drake, C. G.; Freeman, G. J.; Ibrahim, R.; Patel, S.; Chen, D. S. |
| Article Title: | New Cancer Immunotherapy Agents in Development: A report from an associated program of the 31st Annual Meeting of the Society for Immunotherapy of Cancer, 2016 |
| Abstract: | This report is a summary of 'New Cancer Immunotherapy Agents in Development' program, which took place in association with the 31st Annual Meeting of the Society for Immunotherapy of Cancer (SITC), on November 9, 2016 in National Harbor, Maryland. Presenters gave brief overviews of emerging clinical and pre-clinical immune-based agents and combinations, before participating in an extended panel discussion with multidisciplinary leaders, including members of the FDA, leading academic institutions and industrial drug developers, to consider topics relevant to the future of cancer immunotherapy. © 2017 The Author(s). |
| Keywords: | immunotherapy; combination therapy; pd-1; cancer; checkpoint inhibitors |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 5 |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2017-06-20 |
| Start Page: | 50 |
| Language: | English |
| DOI: | 10.1186/s40425-017-0253-2 |
| PROVIDER: | scopus |
| PMCID: | PMC5477277 |
| PUBMED: | 28649381 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 2 August 2017 -- Source: Scopus |
